Dr. Tillmanns is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7945 Wolf River Blvd
Germantown, TN 38138Phone+1 901-683-0055Fax+1 901-922-6701
Education & Training
- University of Oklahoma Health Sciences CenterResidency, Obstetrics and Gynecology, 2000 - 2003
- Medical College of Wisconsin Affiliated HospitalsResidency, Obstetrics and Gynecology, 1996 - 2000
- Creighton University School of MedicineClass of 1996
- University of Oklahoma Health Sciences CenterFellowship, Gynecologic Oncology
Certifications & Licensure
- AR State Medical License 2012 - 2025
- MS State Medical License 2003 - 2025
- TN State Medical License 2003 - 2025
- OK State Medical License 2000 - 2004
- WI State Medical License 1997 - 2001
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2009-2012
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Laparoscopic Approach to Cervical Cancer Start of enrollment: 2008 Jan 01
- Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic Tumors Start of enrollment: 2009 Apr 01
- Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer Start of enrollment: 2009 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Advanced endometrial cancer-The next generation of treatment: A society of gynecologic oncology journal club clinical commentary.Todd Tillmanns, Amal Masri, Chelsea Stewart, Dana Chase, Anthony Karnezis
Gynecologic Oncology Reports. 2024-10-01 - 43 citationsDurvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase I...Shannon N Westin, Kathleen Moore, Hye Sook Chon, Jung-Yun Lee, Jessica Thomes Pepin
Journal of Clinical Oncology. 2024-01-20 - 1 citationsA rare case of follicular dendritic sarcoma of the vagina.Joann M Gold, Naixin Zhang, Ben Wilson, Amal Masri, Laura Bagwell
Gynecologic Oncology Reports. 2022-08-01
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: